Sarah Lyon’s experience spans over 15 years of increasing leadership roles in the medical device industry. Most recently, she served as Vice President, Market Access and Strategic Marketing for Respicardia, a company with a novel sleep medicine neurostimulation therapy that was acquired by ZOLL Medical. Before joining ZOLL Respicardia, Ms. Lyon spent 10 years at Medtronic driving new therapy commercialization in various leadership roles. She brings expertise in new technology commercialization, reimbursement and health economics, payer advocacy and pathway development. She also brings strategy consulting and financial services experience with a focus on healthcare M&A and commercial strategy. Ms. Lyon holds a bachelors of arts degree in economics from St. Olaf College and masters of business administration from The Wharton School of Business.